Applications Manager
at RedShiftBio
Valerie joined RedShiftBio in 2018 and her experience with Microfluidic Modulation Spectroscopy began prior to that, as the first external beta tester of the company’s original AQS3pro system. Valerie possesses a wealth of biophysical characterization experience and a research background in structural and spectroscopic characterization of proteins and peptides, focusing on amyloidosis. Valerie leads RedShiftBio’s internal and external field applications team and oversees all proof-of-concept studies worldwide.
Got a Question for Dr. Valerie Collins?
Get in touch using the contact form linked here and we’ll get back to you shortly.
Characterizing Recombinant Lactoferrin for Human Consumption
Recombinant hLF (rhLF) has been expressed in yeast at an industrial scale, with the aim of making it affordable and accessible as a supplement.
This webinar takes a deep dive into how rhLF can be characterized and analyzed to ensure its safety for consumption in clinical studies.
Our expert speaker will cover how various analytical techniques – including microfluidic modulation spectroscopy – can confirm identity, assess purity and impurities, measure size and investigate the structure of rhLF, as well as compare it to native hLF.
Novel Protein Characterization for Biopharma Development
In this webinar, our expert speakers will demonstrate how thermal and pressure stress changed the structure and melting point of two model proteins and resulted in the discovery of different structural rearrangements.
They will then discuss a novel method for solubilizing and refolding proteins using hydrostatic pressure to generate proteins whose structure matches that of the native protein, as confirmed by microfluidic modulation spectroscopy.
